Proteomics Market Growth, Size, Share, Forecast by 2030
[Research Report] The proteomics market size is projected to surge from US$ 27.07 billion in 2022 to US$ 75.03 billion by 2030; the market is estimated to record a CAGR of 13.6% during 2022–2030.
Analyst Perspective:
The report includes growth prospects owing to the current proteomics market trends and their foreseeable impact during the forecast period. Proteomics is the study of proteomes on a large scale. A set of proteins formed by a biological entity is known as a proteome. A proteome is not constant; it differs from cell to cell and changes over time. A proteome partially reflects the underlying transcriptome, which can also be defined as an organism's full range of messenger RNA molecules. Numerous factors influence protein activity in addition to the level of expression of a particular gene. Proteomics has numerous applications. Thus, the proteomics market is expected to grow considerably due to the increased demand for personalized medicines and increased research and development in proteomics. However, the strict regulatory requirements and dearth of skilled professionals hamper the market growth.
Market Overview:
The large-scale study of the structure and function of proteins is known as proteomics. It encompasses the rapidly evolving field of disease proteomics, which aims to identify proteins involved in human diseases and understand how their expression, structure, and function cause disease. Key factors driving the proteomics market growth include the increasing cases of cancer and other diseases. Ongoing research in proteomics can help doctors understand how proteins react in highly dynamic environments, such as in cancer patients. This is because proteomics obtains important information in the form of biomarkers. Furthermore, proteomics has proven to show significant progress. Additionally, the science of nano proteomics is expected to positively impact the market size in the coming years.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Proteomics Market: Strategic Insights
Market Size Value in US$ 27.07 billion in 2022 Market Size Value by US$ 75.03 billion by 2030 Growth rate CAGR of 13.6% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Proteomics Market: Strategic Insights
| Market Size Value in | US$ 27.07 billion in 2022 |
| Market Size Value by | US$ 75.03 billion by 2030 |
| Growth rate | CAGR of 13.6% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Driver:
Increasing Cases of Chronic Diseases Propels Market Growth
The growing number of cases of chronic diseases such as cancer, respiratory diseases, chronic kidney disease (CKD), cardiovascular diseases (CVDs), and others is another factor expected to drive market growth. For example, according to Globocan, in December 2020, there were ~19.3 million new-found cancer cases worldwide, and 10 million cancer-related deaths were reported. Cardiovascular diseases are also one of the most common causes of death worldwide. For example, the WHO (2021) states that target diseases kill 41 million patients annually. Due to the increasing cases of life-threatening diseases, there is a growing demand for personalized therapies, which positively impacts the industry.
As a large number of populations around the world suffer from cancer, the need for treatments has increased significantly. Many discoveries are also being made in the field of life sciences. The characterization of human proteins is a milestone in biomedicine. Assessing gene expression at the proteome level is also important. Continuous research and development in this field will lead to significant growth in the proteomics market. This technique could provide extremely important biological information that will help understand the biology of cancer patients. Such growing cases of chronic diseases bolster the demand for proteomics.
Segmental Analysis:
The proteomics market analysis has been carried out by considering the following segments: product & service, application, and end user.
Based on product & service, the proteomics market is segmented into instrumentation technologies, reagents & consumables, and software & services. The reagents & consumables segment held the largest market share in 2022 and is estimated to register the highest CAGR of 14.1% during 2022–2030. During the forecast period, this value is likely to increase because of the growing use of reagents & kits, consumables, and strips for studying various biological materials in research universities, research institutions, and other areas. Increasing government initiatives to support the field of proteomics and genomics, as well as increasing research activities in disease diagnostics, will also drive the proteomics market growth. Additionally, technical advancements in advanced instruments, such as 3D electrophoresis protein analyzers, which increase biological research's speed, efficiency, and productivity, which will subsequently promote market expansion.
The market, based on application, is divided into clinical diagnostics, drug discovery & development, and others. The clinical diagnostics segment held the largest proteomics market share in 2022 due to researchers and clinicians' widespread use of protein analysis to identify disease biomarkers for early detection of risk factors. Also, it is possible to discover potential protein transcription regulation that can be used to identify and predict malignancies and evaluate their prognosis using proteomics-based diagnosis.
Based on end user, the proteomics market is divided into pharmaceutical & biotechnology companies, research & clinical laboratories, hospitals, and others. The pharmaceutical & biotechnology companies segment held the largest proteomics market share in 2022. However, the research & clinical laboratories segment is anticipated to register the highest CAGR of 14.5% during 2022–2030. Increasing R&D funding from pharmaceutical and biotechnology companies to develop novel drugs is expected to boost the demand for proteomics services. Additionally, the need for enzymes, reagents, and kits is fueled by increased research and development activities, several ongoing proteomics studies to treat various life-threatening diseases, and increased life science projects in research and academic settings.
Regional Analysis:
The scope of the proteomics market report includes North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The market in North America was valued at US$ 11.95 billion in 2022 and is projected to reach US$ 33.56 billion by 2030; it is expected to register a CAGR of 13.8% during 2022–2030. One of the key factors driving the market growth in this region is the increasing investments for the development of structure-based drug design, demand for high-quality research tools for data reproducibility, growth in omics research, etc. Attention is being paid to the development of tailor-made treatments. The partnerships and collaborations between major regional companies also contribute to this market expansion. For example, Thermo Fisher Scientific Inc. and Symphogen have collaborated to develop verified platform processes for optimized characterization and quality monitoring of complex therapeutic proteins. Several protein therapies are being tested in clinical trials to treat cancer, infections, immunological disorders, age-related diseases, and other problems. Additionally, proteomics research is at its peak in countries such as the US owing to the high incidence of inherited diseases such as Alzheimer's, as well as infectious diseases such as malaria and tuberculosis, in the region.
The Asia Pacific proteomics market is expected to record the fastest CAGR of 14.3%. The region, especially with countries such as India and China, is home to a sizable pharmaceutical industry. China is a pharmaceutical manufacturing hub. The projected market growth in this region is attributed to the availability of highly functional manufacturing units and contract manufacturing facilities in the region. Further, a huge population base susceptible to cancer and other infectious diseases, extensive use of proteomics in diagnosing genetic disorders, and increasing R&D spending and social programs are expected to propel the need for proteome-based disease diagnosis, thereby boosting the market growth.
Proteomics Market Report Scope
Key Player Analysis:
Proteome Sciences; Biognosys; Creative Proteomics; Shantani; Olink; SomaLogic Operating Co., Inc.; QUANTUM-SI INCORPORATED; Proteomics International; Promise Proteomics; SCIEX; Illumina, Inc.; and Thermo Fisher Scientific Inc are among the key players profiled in the proteomics market report.
Recent Developments:
Companies operating in the proteomics market adopt mergers and acquisitions as key growth strategies. As per company press releases, a few recent market developments are listed below:
- In June 2022, SomaLogic and Illumina, Inc. announced a joint development agreement in which companies will utilize the SomaScan Proteomics Assay on Illumina's current and future high-throughput next-generation sequencing (NGS) platforms. The partnership accelerated next-generation sequencing in the proteomics market's fast-growing, ultra-high throughput workflow.
- In May 2022, Proteomics International Laboratories Ltd received US$ 13,516 in funding to enable the production of its PromarkerD clinical diagnostic in Australia, the world's first diagnostic, predictive test for diabetes-related kidney disease. The program aims to foster new health innovations, advance discoveries toward proof-of-concept and commercialization that address important health problems and maximize entrepreneurial and idea potential.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product & Service, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors driving the growth of the proteomics market include the proliferating cases of chronic diseases and growing prominence of nano proteomics.
The proteomics market majorly consists of the players such as Proteome Sciences, Biognosys, Creative Proteomics, Shantani, Olink, SomaLogic Operating Co., Inc.; QUANTUM-SI INCORPORATED, Proteomics International, Promise Proteomics, SCIEX, Illumina, Inc.; and Thermo Fisher Scientific Inc.
The proteomics market is expected to be valued at US$ 75.03 billion in 2030.
The global proteomics market, based on product & service is segmented into instrumentation technologies, reagents & consumables, and software & services. The reagents & consumables segment held a larger proteomics market share in 2022, and the same is predicted to register a higher CAGR of 14.1% during 2022–2030. Based on application, market is segmented into clinical diagnostics, drug discovery & development, and others. The clinical diagnostics segment held the largest proteomics market share in 2022. However, the drug discovery & development segment is estimated to register the highest CAGR of 14.4% during 2022–2030. Based on end user, the market is segmented into pharmaceutical & biotechnology companies, research & clinical laboratories, hospitals, others. The pharmaceutical & biotechnology companies segment held the largest proteomics market share in 2022. However, the research & clinical laboratories segment is estimated to register the highest CAGR of 14.5% during 2022–2030.
The proteomics market was valued at US$ 27.07 billion in 2022.
Proteomics, the detailed analysis of proteins, has become a significant field to study drug development, therapy, prognosis, and disease characterization. Proteomics technologies help with both infectious and noninfectious disease detection and therapy. The current proteomic methodologies are being made more reliable, biocompatible, specific, and reproducible through the use of nanotechnology as a technological platform. The shortcomings of conventional proteomic techniques are greatly assessed with the use of nanomaterials to enhance the quality of proteomic techniques by protein manipulation.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Proteomics Market - By Instrument
1.3.2 Proteomics Market - By Reagents
1.3.3 Proteomics Market - By Services and Software
1.3.4 Proteomics Market - By Application
1.3.5 Proteomics Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PROTEOMICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PROTEOMICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PROTEOMICS MARKET - GLOBAL MARKET ANALYSIS
6.1. PROTEOMICS - GLOBAL MARKET OVERVIEW
6.2. PROTEOMICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - INSTRUMENT
7.1. OVERVIEW
7.2. INSTRUMENT MARKET FORECASTS AND ANALYSIS
7.3. SPECTROSCOPY
7.3.1. Overview
7.3.2. Spectroscopy Market Forecast and Analysis
7.3.3. Mass Spectroscopy Market
7.3.3.1. Overview
7.3.3.2. Mass Spectroscopy Market Forecast and Analysis
7.3.4. NMR Spectroscopy Market
7.3.4.1. Overview
7.3.4.2. NMR Spectroscopy Market Forecast and Analysis
7.3.5. Circular Dichroism (CD) Spectroscopy Market
7.3.5.1. Overview
7.3.5.2. Circular Dichroism (CD) Spectroscopy Market Forecast and Analysis
7.4. CHROMATOGRAPHY
7.4.1. Overview
7.4.2. Chromatography Market Forecast and Analysis
7.4.3. HPLC Market
7.4.3.1. Overview
7.4.3.2. HPLC Market Forecast and Analysis
7.4.4. Ion Chromatography Market
7.4.4.1. Overview
7.4.4.2. Ion Chromatography Market Forecast and Analysis
7.4.5. Ion Chromatography Market
7.4.5.1. Overview
7.4.5.2. Ion Chromatography Market Forecast and Analysis
7.4.6. Supercritical Fluid Chromatography Market
7.4.6.1. Overview
7.4.6.2. Supercritical Fluid Chromatography Market Forecast and Analysis
7.5. ELECTROPHORESIS
7.5.1. Overview
7.5.2. Electrophoresis Market Forecast and Analysis
7.5.3. Gel Electrophoresis Market
7.5.3.1. Overview
7.5.3.2. Gel Electrophoresis Market Forecast and Analysis
7.5.4. Capillary Electrophoresis Market
7.5.4.1. Overview
7.5.4.2. Capillary Electrophoresis Market Forecast and Analysis
7.6. PROTEIN MICROARRAYS
7.6.1. Overview
7.6.2. Protein Microarrays Market Forecast and Analysis
7.6.3. Biochips Market
7.6.3.1. Overview
7.6.3.2. Biochips Market Forecast and Analysis
7.6.4. Microarray Instruments Market
7.6.4.1. Overview
7.6.4.2. Microarray Instruments Market Forecast and Analysis
7.7. X-RAY CRYSTALLOGRAPHY
7.7.1. Overview
7.7.2. X-Ray Crystallography Market Forecast and Analysis
7.8. SURFACE PLASMON RESONANCE
7.8.1. Overview
7.8.2. Surface Plasmon Resonance Market Forecast and Analysis
7.9. PROTEIN FRACTIONATION
7.9.1. Overview
7.9.2. Protein Fractionation Market Forecast and Analysis
7.10. OTHER INSTRUMENT
7.10.1. Overview
7.10.2. Other Instrument Market Forecast and Analysis
8. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - REAGENTS
8.1. OVERVIEW
8.2. REAGENTS MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOASSAY REAGENTS
8.3.1. Overview
8.3.2. Immunoassay Reagents Market Forecast and Analysis
8.4. SPECTROSCOPY REAGENTS
8.4.1. Overview
8.4.2. Spectroscopy Reagents Market Forecast and Analysis
8.5. CHROMATOGRAPHY REAGENTS
8.5.1. Overview
8.5.2. Chromatography Reagents Market Forecast and Analysis
8.6. PROTEIN MICROARRAY REAGENTS
8.6.1. Overview
8.6.2. Protein Microarray Reagents Market Forecast and Analysis
8.7. X-RAY CRYSTALLOGRAPHY REAGENTS
8.7.1. Overview
8.7.2. X-Ray Crystallography Reagents Market Forecast and Analysis
8.8. ELECTROPHORESIS REAGENTS
8.8.1. Overview
8.8.2. Electrophoresis Reagents Market Forecast and Analysis
8.9. PROTEIN FRACTIONATION REAGENTS
8.9.1. Overview
8.9.2. Protein Fractionation Reagents Market Forecast and Analysis
9. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - SERVICES AND SOFTWARE
9.1. OVERVIEW
9.2. SERVICES AND SOFTWARE MARKET FORECASTS AND ANALYSIS
9.3. SERVICES
9.3.1. Overview
9.3.2. Services Market Forecast and Analysis
9.3.3. Protein Identification Services Market
9.3.3.1. Overview
9.3.3.2. Protein Identification Services Market Forecast and Analysis
9.3.4. Quantitative Proteomics Services Market
9.3.4.1. Overview
9.3.4.2. Quantitative Proteomics Services Market Forecast and Analysis
9.3.5. Protein Purification Services Market
9.3.5.1. Overview
9.3.5.2. Protein Purification Services Market Forecast and Analysis
9.3.6. Protein Separation Services Market
9.3.6.1. Overview
9.3.6.2. Protein Separation Services Market Forecast and Analysis
9.3.7. Protein Sequencing Services Market
9.3.7.1. Overview
9.3.7.2. Protein Sequencing Services Market Forecast and Analysis
9.3.8. Others Services Market
9.3.8.1. Overview
9.3.8.2. Others Services Market Forecast and Analysis
9.4. SOFTWARE
9.4.1. Overview
9.4.2. Software Market Forecast and Analysis
9.4.3. Bioinformatics Services Market
9.4.3.1. Overview
9.4.3.2. Bioinformatics Services Market Forecast and Analysis
9.4.4. Bioinformatics Tools Market
9.4.4.1. Overview
9.4.4.2. Bioinformatics Tools Market Forecast and Analysis
9.4.5. Bioinformatics Databases Market
9.4.5.1. Overview
9.4.5.2. Bioinformatics Databases Market Forecast and Analysis
10. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
10.1. OVERVIEW
10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. CLINICAL DIAGNOSTICS
10.3.1. Overview
10.3.2. Clinical Diagnostics Market Forecast and Analysis
10.4. DRUG DISCOVERY
10.4.1. Overview
10.4.2. Drug Discovery Market Forecast and Analysis
10.5. OTHER APPLICATIONS
10.5.1. Overview
10.5.2. Other Applications Market Forecast and Analysis
11. PROTEOMICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Proteomics Market Overview
11.1.2 North America Proteomics Market Forecasts and Analysis
11.1.3 North America Proteomics Market Forecasts and Analysis - By Instrument
11.1.4 North America Proteomics Market Forecasts and Analysis - By Reagents
11.1.5 North America Proteomics Market Forecasts and Analysis - By Services and Software
11.1.6 North America Proteomics Market Forecasts and Analysis - By Application
11.1.7 North America Proteomics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Proteomics Market
11.1.7.1.1 United States Proteomics Market by Instrument
11.1.7.1.2 United States Proteomics Market by Reagents
11.1.7.1.3 United States Proteomics Market by Services and Software
11.1.7.1.4 United States Proteomics Market by Application
11.1.7.2 Canada Proteomics Market
11.1.7.2.1 Canada Proteomics Market by Instrument
11.1.7.2.2 Canada Proteomics Market by Reagents
11.1.7.2.3 Canada Proteomics Market by Services and Software
11.1.7.2.4 Canada Proteomics Market by Application
11.1.7.3 Mexico Proteomics Market
11.1.7.3.1 Mexico Proteomics Market by Instrument
11.1.7.3.2 Mexico Proteomics Market by Reagents
11.1.7.3.3 Mexico Proteomics Market by Services and Software
11.1.7.3.4 Mexico Proteomics Market by Application
11.2. EUROPE
11.2.1 Europe Proteomics Market Overview
11.2.2 Europe Proteomics Market Forecasts and Analysis
11.2.3 Europe Proteomics Market Forecasts and Analysis - By Instrument
11.2.4 Europe Proteomics Market Forecasts and Analysis - By Reagents
11.2.5 Europe Proteomics Market Forecasts and Analysis - By Services and Software
11.2.6 Europe Proteomics Market Forecasts and Analysis - By Application
11.2.7 Europe Proteomics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Proteomics Market
11.2.7.1.1 Germany Proteomics Market by Instrument
11.2.7.1.2 Germany Proteomics Market by Reagents
11.2.7.1.3 Germany Proteomics Market by Services and Software
11.2.7.1.4 Germany Proteomics Market by Application
11.2.7.2 France Proteomics Market
11.2.7.2.1 France Proteomics Market by Instrument
11.2.7.2.2 France Proteomics Market by Reagents
11.2.7.2.3 France Proteomics Market by Services and Software
11.2.7.2.4 France Proteomics Market by Application
11.2.7.3 Italy Proteomics Market
11.2.7.3.1 Italy Proteomics Market by Instrument
11.2.7.3.2 Italy Proteomics Market by Reagents
11.2.7.3.3 Italy Proteomics Market by Services and Software
11.2.7.3.4 Italy Proteomics Market by Application
11.2.7.4 Spain Proteomics Market
11.2.7.4.1 Spain Proteomics Market by Instrument
11.2.7.4.2 Spain Proteomics Market by Reagents
11.2.7.4.3 Spain Proteomics Market by Services and Software
11.2.7.4.4 Spain Proteomics Market by Application
11.2.7.5 United Kingdom Proteomics Market
11.2.7.5.1 United Kingdom Proteomics Market by Instrument
11.2.7.5.2 United Kingdom Proteomics Market by Reagents
11.2.7.5.3 United Kingdom Proteomics Market by Services and Software
11.2.7.5.4 United Kingdom Proteomics Market by Application
11.2.7.6 Rest of Europe Proteomics Market
11.2.7.6.1 Rest of Europe Proteomics Market by Instrument
11.2.7.6.2 Rest of Europe Proteomics Market by Reagents
11.2.7.6.3 Rest of Europe Proteomics Market by Services and Software
11.2.7.6.4 Rest of Europe Proteomics Market by Application
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Proteomics Market Overview
11.3.2 Asia-Pacific Proteomics Market Forecasts and Analysis
11.3.3 Asia-Pacific Proteomics Market Forecasts and Analysis - By Instrument
11.3.4 Asia-Pacific Proteomics Market Forecasts and Analysis - By Reagents
11.3.5 Asia-Pacific Proteomics Market Forecasts and Analysis - By Services and Software
11.3.6 Asia-Pacific Proteomics Market Forecasts and Analysis - By Application
11.3.7 Asia-Pacific Proteomics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Proteomics Market
11.3.7.1.1 Australia Proteomics Market by Instrument
11.3.7.1.2 Australia Proteomics Market by Reagents
11.3.7.1.3 Australia Proteomics Market by Services and Software
11.3.7.1.4 Australia Proteomics Market by Application
11.3.7.2 China Proteomics Market
11.3.7.2.1 China Proteomics Market by Instrument
11.3.7.2.2 China Proteomics Market by Reagents
11.3.7.2.3 China Proteomics Market by Services and Software
11.3.7.2.4 China Proteomics Market by Application
11.3.7.3 India Proteomics Market
11.3.7.3.1 India Proteomics Market by Instrument
11.3.7.3.2 India Proteomics Market by Reagents
11.3.7.3.3 India Proteomics Market by Services and Software
11.3.7.3.4 India Proteomics Market by Application
11.3.7.4 Japan Proteomics Market
11.3.7.4.1 Japan Proteomics Market by Instrument
11.3.7.4.2 Japan Proteomics Market by Reagents
11.3.7.4.3 Japan Proteomics Market by Services and Software
11.3.7.4.4 Japan Proteomics Market by Application
11.3.7.5 South Korea Proteomics Market
11.3.7.5.1 South Korea Proteomics Market by Instrument
11.3.7.5.2 South Korea Proteomics Market by Reagents
11.3.7.5.3 South Korea Proteomics Market by Services and Software
11.3.7.5.4 South Korea Proteomics Market by Application
11.3.7.6 Rest of Asia-Pacific Proteomics Market
11.3.7.6.1 Rest of Asia-Pacific Proteomics Market by Instrument
11.3.7.6.2 Rest of Asia-Pacific Proteomics Market by Reagents
11.3.7.6.3 Rest of Asia-Pacific Proteomics Market by Services and Software
11.3.7.6.4 Rest of Asia-Pacific Proteomics Market by Application
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Proteomics Market Overview
11.4.2 Middle East and Africa Proteomics Market Forecasts and Analysis
11.4.3 Middle East and Africa Proteomics Market Forecasts and Analysis - By Instrument
11.4.4 Middle East and Africa Proteomics Market Forecasts and Analysis - By Reagents
11.4.5 Middle East and Africa Proteomics Market Forecasts and Analysis - By Services and Software
11.4.6 Middle East and Africa Proteomics Market Forecasts and Analysis - By Application
11.4.7 Middle East and Africa Proteomics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Proteomics Market
11.4.7.1.1 South Africa Proteomics Market by Instrument
11.4.7.1.2 South Africa Proteomics Market by Reagents
11.4.7.1.3 South Africa Proteomics Market by Services and Software
11.4.7.1.4 South Africa Proteomics Market by Application
11.4.7.2 Saudi Arabia Proteomics Market
11.4.7.2.1 Saudi Arabia Proteomics Market by Instrument
11.4.7.2.2 Saudi Arabia Proteomics Market by Reagents
11.4.7.2.3 Saudi Arabia Proteomics Market by Services and Software
11.4.7.2.4 Saudi Arabia Proteomics Market by Application
11.4.7.3 U.A.E Proteomics Market
11.4.7.3.1 U.A.E Proteomics Market by Instrument
11.4.7.3.2 U.A.E Proteomics Market by Reagents
11.4.7.3.3 U.A.E Proteomics Market by Services and Software
11.4.7.3.4 U.A.E Proteomics Market by Application
11.4.7.4 Rest of Middle East and Africa Proteomics Market
11.4.7.4.1 Rest of Middle East and Africa Proteomics Market by Instrument
11.4.7.4.2 Rest of Middle East and Africa Proteomics Market by Reagents
11.4.7.4.3 Rest of Middle East and Africa Proteomics Market by Services and Software
11.4.7.4.4 Rest of Middle East and Africa Proteomics Market by Application
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Proteomics Market Overview
11.5.2 South and Central America Proteomics Market Forecasts and Analysis
11.5.3 South and Central America Proteomics Market Forecasts and Analysis - By Instrument
11.5.4 South and Central America Proteomics Market Forecasts and Analysis - By Reagents
11.5.5 South and Central America Proteomics Market Forecasts and Analysis - By Services and Software
11.5.6 South and Central America Proteomics Market Forecasts and Analysis - By Application
11.5.7 South and Central America Proteomics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Proteomics Market
11.5.7.1.1 Brazil Proteomics Market by Instrument
11.5.7.1.2 Brazil Proteomics Market by Reagents
11.5.7.1.3 Brazil Proteomics Market by Services and Software
11.5.7.1.4 Brazil Proteomics Market by Application
11.5.7.2 Argentina Proteomics Market
11.5.7.2.1 Argentina Proteomics Market by Instrument
11.5.7.2.2 Argentina Proteomics Market by Reagents
11.5.7.2.3 Argentina Proteomics Market by Services and Software
11.5.7.2.4 Argentina Proteomics Market by Application
11.5.7.3 Rest of South and Central America Proteomics Market
11.5.7.3.1 Rest of South and Central America Proteomics Market by Instrument
11.5.7.3.2 Rest of South and Central America Proteomics Market by Reagents
11.5.7.3.3 Rest of South and Central America Proteomics Market by Services and Software
11.5.7.3.4 Rest of South and Central America Proteomics Market by Application
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PROTEOMICS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. PROTEOMICS MARKET, KEY COMPANY PROFILES
14.1. THERMO FISHER SCIENTIFIC INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. BIO-RAD LABORATORIES, INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. AGILENT TECHNOLOGIES
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. DANAHER
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. PERKINELMER INC.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. MERCK KGAA
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. LUMINEX CORPORATION
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. GENERAL ELECTRIC COMPANY
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and S
The List of Companies - Proteomics Market
- Proteome Sciences
- Biognosys
- Creative Proteomics
- Shantani
- Olink
- SomaLogic Operating Co., Inc.
- QUANTUM-SI INCORPORATED
- Proteomics International
- Promise Proteomics
- SCIEX
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For